Computerized clinical decision support (CDS) faces challenges to interoperability and scalability. Centralized, web-based solutions offer a mechanism to share the cost of CDS development, maintenance, and implementation across practices. Data standards have emerged to facilitate interoperability and rapid integration of such third-party CDS. This case report describes the challenges to implementation and scalability of an integrated, web-based CDS intervention for EMergency department-initiated BuprenorphinE for opioid use Disorder which will soon be evaluated in a trial across 20 sites in five healthcare systems. Due to limitations of current standards, security concerns, and the need for resource-intensive local customization, barriers persist related to centralized CDS at this scale. These challenges demonstrate the need and importance for future standards to support two-way messaging (read and write) between electronic health records and web applications, thus allowing for more robust sharing across health systems and decreasing redundant, resource-intensive CDS development at individual sites.
INTRODUCTION

Overview
Computerized clinical decision support (CDS) has proven potential to increase the adoption of evidence-based medicine. 1, 2 In particular, CDS has been successful in improving adoption of medicationrelated best practices. [3] [4] [5] However, customizing local CDS solutions often involves significant costs due to the technical infrastructure and staff expertise required. 6, 7 In response, centralized web servicebased CDS models have emerged as a mechanism to share the cost of development, maintenance, and implementation across practices. 6 In addition, data standards such as Fast Healthcare Interoperability Resources (FHIR) and specifications such as Substitutable Medical Apps and Reusable Technology (SMART) and CDS-Hooks have been proposed to facilitate interoperability and rapid integration of these third-party CDS into electronic health record (EHR) systems. 7 
EMBED project context (EMergency departmentinitiated BuprenorphinE for opioid use Disorder)
Approximately 2.1 million Americans have opioid use disorder (OUD). 8 The cost of the opioid crisis has been estimated to be greater than $500 billion per year. 9 There were 47 600 opioidrelated overdose deaths in the United States in 2017, representing 67.8% of all drug overdose deaths. 10 People with OUD often seek care in the emergency department (ED) for complications and morbidity associated with opioid use, contributing to a 30% increase in ED visits for opioid overdose from 2016 to 2017. 11 These visits offer an important opportunity to engage patients in treatment for OUD. 12 Medications for OUD (MOUD), specifically opioid agonists such as methadone and buprenorphine/naloxone (BUP), can safely and effectively treat OUD by decreasing future opioid use, mortality, craving, and withdrawal symptoms while also increasing retention in treatment. [13] [14] [15] A 2015 randomized clinical trial involving 329 patients with OUD showed that BUP could be safely initiated in the ED. Furthermore, patients in the BUP intervention group were twice as likely to be engaged in addiction treatment at 30 days (78% vs 37%). 16 A retrospective cohort study of 17 568 adults who survived an opioid overdose showed that all-cause mortality at 12 months dropped from 4.7% (95% confidence interval 4.4-5.0) to 2.0% (95% confidence interval 1.3-2.7) in persons receiving BUP treatment.
14 Despite this treatment effect, initiation of BUP has not been adopted as routine emergency care for people with OUD. 17, 18 This is partly due to emergency clinicians' perception that the practice of initiation of BUP is unfamiliar, complicated, and time consuming, problems which are only exacerbated by the dynamic ED context. 12, 19 To overcome these barriers and leverage the ED as a critical opportunity to treat OUD, we developed a CDS solution to assist emergency clinicians with the processes and decisions that are necessary to initiate BUP for OUD patients such that this practice could be simplified to a few clicks in the EHR. The CDS was implemented with the goal of optimizing its usability, EHR integration, automation of EHR workflow, and scalability across a variety of healthcare systems. Here, we report the technical details, challenges, and lessons learned while implementing this CDS.
CASE DESCRIPTION
Setting
The EMergency department-initiated BuprenorphinE for opioid use Disorder (EMBED) CDS was developed to serve as the intervention in a pragmatic trial that compares the effectiveness of CDS with an automated and EHR-integrated workflow to usual care on the adoption of ED-initiation of BUP in emergency care. [20] [21] [22] This 18-month parallel, cluster-randomized trial will evaluate the intervention in 20 EDs in 5 healthcare systems nationally. 22 The EMBED intervention was intended to be vendor-agnostic and capable of integration within multiple healthcare systems; each health system in the trial utilizes a different EHR platform and/or different build of the same vendor's product.
Integration needs for automated workflow
Full details of the user-centered design have been previously reported. 20 Twenty-six ED physicians expressed needs in four key areas that would allow CDS to support ED-initiation of BUP:
(1) identify patients appropriately, (2) avoid workflow disruptions, (3) streamline clerical burden, and (4) help users understand the treatment process. Specifically, the application would need to offer a patient-specific, rapid, integrated, automated care pathway as well as optional support in diagnosing OUD, assessing withdrawal severity, and motivating readiness for treatment.
Features
Due to the limited flexibility of CDS customization available from our EHR vendor at the time of initial development, an EHRintegrated web application was created with a graphical user interface similar to the final design prototype. This was intended to allow for future interoperability with other EHR platforms. As our primary health system used Epic (Epic Systems, Verona, WI), we first focused on integration with the Epic EHR. First, we evaluated development of a SMART on FHIR application. At that time, Epic's FHIR server did not support the requirements described above. After a comprehensive review of other application architectures, the decision was made to utilize the Epic Active Guidelines (AGL) framework. AGL provides multiple advantages compared to generic SMART on FHIR, primarily an ability to directly interact with Epic through a dedicated Application Programming Interface (API). While other major EHR vendors may support similar functionality in the future, the key limitation of AGL is that it is currently supported only by Epic.
AGL was used to seamlessly integrate the EMBED web application directly into the user's EHR workflow. The application is accessible from the navigation bar directly in a patient's chart. In technical terms, the web application is launched in a dedicated sandboxed environment using an iframe (ie, a page from one domain is framed inside a page from another domain). AGL was developed using an HTML5 web messaging protocol to allow secure communication between a trusted web application and the Epic AGL API. When launched, the application receives an authentication token which is used for direct communication between the web application and the EHR.
The EMBED web application automates a care pathway that includes patient-specific orders (ED medications, prescriptions, and referral) and documentation (a note in the chart reflecting the use of the app and discharge instructions). When the user launches one of seven potential care pathways in the web application, a message is sent back to the EHR with order preference and treatment pathway identification numbers (Figure 1 ). Epic's Flowsheet functionality is used to select a documentation SmartText (ETX) corresponding to a numerical value (1-7). Another ETX pulls narrative details of the care pathway into a clinical note. To increase flexibility with documentation, an Epic SmartPhrase is also available for users to alternatively insert documentation of the selected care pathway.
With these features, the EMBED intervention streamlines the process of BUP initiation in the ED effectively transforming a complicated algorithm into an automated workflow. From a clinician's perspective, the "EMBED" button is clicked within a patient's EHR chart. Next, they are guided through the process of choosing the best care pathway with the help of three optional decision support tools (Figure 2 ). These tools assist with diagnosing OUD, assessing withdrawal severity, and motivating patient readiness to begin treatment. Once a specific treatment pathway is launched, the application automatically sends the corresponding orders and prescriptions, completes documentation and discharge instructions, and provides choices for local referral sites. At any point, users may still alter these clinical activities to further customize them for a specific patient.
CHALLENGES & LESSONS LEARNED
Implementation of this user-centered CDS for ED-initiation of BUP for a large pragmatic trial faced multiple challenges. Despite the effectiveness of BUP-both long term and when initiated in the EDthere are multiple barriers to increasing adoption of ED-initiation of BUP into routine emergency care. 23 A qualitative study of centralized CDS services implemented across four sites which analyzed clinical observations and 91 interviews previously identified challenges and lessons learned in eight domains including infrastructure, interface, people, workflow, environment, regulations, and monitoring. 24 We add to this knowledge base by presenting the specific challenges and lessons learned in the EMBED implementation (Table 1) so that healthcare systems outside of the trial network can accelerate the adoption of the EMBED intervention-or similar interventions. The automated and usable intervention that we have implemented has the potential to make ED-initiation of BUP simpler, provide the necessary information and tools for diagnosis of OUD, assessment of withdrawal and subsequent treatment algorithms thus helping to overcome the barrier of ED clinicians' perceptions that this treatment protocol is unfamiliar, too complicated, and overly burdensome for use in crowded, chaotic EDs. 12, 20 A strength of the EMBED intervention is that it will be tested in a trial network that includes three healthcare systems using the Epic EHR and two using Cerner Millenium (Cerner Corporation, North Kansas City, MO). Our user-centered design process revealed that EHR native tools were not expressive enough to address users' needs for an efficient interface integrated into the workflow for ED-initiation of BUP. We evaluated the use of SMART on FHIR 25 to allow two-way communication between a centralized application and EHRs within the trial network. Order entry had been identified as a critical component for integration in the design. 20 At that time, Epic's FHIR implementation did not support robust API's for real-time order entry. In the primary EMBED health system, this challenge was overcome using Epic's AGL framework and flowsheet functionality. This solution met local users' needs and has been successfully launched. Our initial CDS implementation took approximately 6 months in the primary health system and was then proposed for dissemination in four secondary health systems comprising the remainder of the trial network. However, informatics leaders in the secondary systems expressed reservation about this build due to: (1) the resources required for local customization and maintenance of a nonstandardsbased intervention and (2) the security limitations and potential loss of control of a centralized, nonstandards-based solution hosted outside of their system. EHR vendors launched new tools after the primary EMBED implementation, such as Epic Smartsets or Cerner Care Pathways, to provide similar integrated, albeit less expressive CDS solutions. As a pragmatic trial, EMBED focuses on "identifying sustainable, generalizable, and evidence-based ways to improve healthcare" in real-world settings. 26, 27 Evaluating the durability of a nonstandards-based solution against a native solution, the secondary health systems made the pragmatic decision to move forward with native, integrated EHR solutions and added-on functionality as necessary to support all of the key components of the EMBED intervention. The interventions implemented in the secondary EMBED healthcare systems will have interfaces and workflows comparable to the primary site and familiar to local clinicians but, with continued maintenance, may diverge from each other over time. Interventions utilizing the Enterprise Clinical Rules Service (ECRS), a centralized, web-based, shareable CDS service, addressed similar challenges to provide consistent, maintainable, and scalable CDS in a variety of settings. 6 ECRS was successfully integrated in a 13-site trial to implement prediction rules in 19 029 children with minor blunt head trauma. 28 At the time of that implementation, researchers hypothesized that maturation of standards for CDS services could decrease time-to-trial for multicenter evaluations. 29 Although trials utilizing the ECRS demonstrated the feasibility of using remote decision support services for multicenter trials, these early efforts were burdened by the lack of integration standards for remote CDS as well as sharing packaged workflows. Since then, FHIR-based specifications, like CDS-Hooks, have matured and grown in adoption. 6 While progress has been made, the EMBED implementation illustrates a continued need for standards to evolve to meet requirements for CDS at scale.
CONCLUSION
The EMBED implementation process elicited many challenges to interoperability and scalability. User-centered CDS can be created to support clinicians needs for initiating BUP therapy in ED patients with OUD. A scalable, centralized CDS solution that meets users' needs for ED-initiation of BUP still remains elusive as it would, at a minimum, require maturation of tools and standards such as SMART on FHIR to include additional clinical activities, specifically order placement and referrals. In response to these challenges, future work in the field should focus on updating interoperability standards themselves. The updated standards could then be used with existing services like ECRS to facilitate the sharing of new technology across health systems and decrease the redundant, resource-intensive development of programs at individual sites.
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